GSK plc reported an increase in shareholdings by senior management due to the reinvestment of dividends paid on October 9, 2025, totaling 8,786.741 shares acquired at £16.40 each on October 10, 2025, at the London Stock Exchange. This filing indicates ongoing investment confidence from the company's executive team.